Market Research Logo

Migraine Drugs

Migraine Drugs

Migraine Drugs market worldwide is projected to grow by US$4.3 Billion, driven by a compounded growth of 18%. Acute Treatment, one of the segments analyzed and sized in this study, displays the potential to grow at over 18.6%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$4.8 Billion by the year 2025, Acute Treatment will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 16% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$162.6 Million to the region's size and clout in the next 5 to 6 years. Over US$135.5 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Acute Treatment will reach a market size of US$237.4 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 23% over the next couple of years and add approximately US$1.1 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include among others, Allergan PLC; Amgen, Inc.; Biohaven Pharmaceutical Holding Company Ltd.; Eli Lilly and Company; GlaxoSmithKline PLC; Johnson & Johnson; Pfizer, Inc.; Teva Pharmaceutical Industries Ltd.

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Competitor Market Shares
Migraine Drugs Competitor Market Share Scenario Worldwide (in %): 2019 & 2028
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: Migraine Drugs Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025
TABLE 2: Migraine Drugs Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2009-2017
TABLE 3: Migraine Drugs Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
TABLE 4: Acute Treatment (Treatment) World Market by Region/Country in US$ Thousand: 2018 to 2025
TABLE 5: Acute Treatment (Treatment) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017
TABLE 6: Acute Treatment (Treatment) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
TABLE 7: Preventive Treatment (Treatment) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025
TABLE 8: Preventive Treatment (Treatment) Historic Market Perspective by Region/Country in US$ Thousand: 2009 to 2017
TABLE 9: Preventive Treatment (Treatment) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
TABLE 10: Triptans (Therapeutic Class) Geographic Market Spread Worldwide in US$ Thousand: 2018 to 2025
TABLE 11: Triptans (Therapeutic Class) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2009 to 2017
TABLE 12: Triptans (Therapeutic Class) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
TABLE 13: Acetylcholine Inhibitors/Neurotoxins (Therapeutic Class) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2018 to 2025
TABLE 14: Acetylcholine Inhibitors/Neurotoxins (Therapeutic Class) Market Historic Review by Region/Country in US$ Thousand: 2009 to 2017
TABLE 15: Acetylcholine Inhibitors/Neurotoxins (Therapeutic Class) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
TABLE 16: Ergot Alkaloids (Therapeutic Class) World Market by Region/Country in US$ Thousand: 2018 to 2025
TABLE 17: Ergot Alkaloids (Therapeutic Class) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017
TABLE 18: Ergot Alkaloids (Therapeutic Class) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
TABLE 19: NSAIDs (Therapeutic Class) World Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018 to 2025
TABLE 20: NSAIDs (Therapeutic Class) Market Worldwide Historic Review by Region/Country in US$ Thousand: 2009 to 2017
TABLE 21: NSAIDs (Therapeutic Class) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025
TABLE 22: Other Therapeutic Classes (Therapeutic Class) Market Opportunity Analysis Worldwide in US$ Thousand by Region/Country: 2018 to 2025
TABLE 23: Other Therapeutic Classes (Therapeutic Class) Global Historic Demand in US$ Thousand by Region/Country: 2009 to 2017
TABLE 24: Other Therapeutic Classes (Therapeutic Class) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
TABLE 25: Oral (Route of Administration) World Market by Region/Country in US$ Thousand: 2018 to 2025
TABLE 26: Oral (Route of Administration) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017
TABLE 27: Oral (Route of Administration) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
TABLE 28: Injectables (Route of Administration) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025
TABLE 29: Injectables (Route of Administration) Historic Market Perspective by Region/Country in US$ Thousand: 2009 to 2017
TABLE 30: Injectables (Route of Administration) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
TABLE 31: Other Route of Administrations (Route of Administration) Geographic Market Spread Worldwide in US$ Thousand: 2018 to 2025
TABLE 32: Other Route of Administrations (Route of Administration) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2009 to 2017
TABLE 33: Other Route of Administrations (Route of Administration) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Migraine Drugs Market Share (in %) by Company: 2019 & 2025
TABLE 34: United States Migraine Drugs Market Estimates and Projections in US$ Thousand by Treatment: 2018 to 2025
TABLE 35: Migraine Drugs Market in the United States by Treatment: A Historic Review in US$ Thousand for 2009-2017
TABLE 36: United States Migraine Drugs Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
TABLE 37: United States Migraine Drugs Market Estimates and Projections in US$ Thousand by Therapeutic Class: 2018 to 2025
TABLE 38: Migraine Drugs Market in the United States by Therapeutic Class: A Historic Review in US$ Thousand for 2009-2017
TABLE 39: United States Migraine Drugs Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
TABLE 40: United States Migraine Drugs Market Estimates and Projections in US$ Thousand by Route of Administration: 2018 to 2025
TABLE 41: Migraine Drugs Market in the United States by Route of Administration: A Historic Review in US$ Thousand for 2009-2017
TABLE 42: United States Migraine Drugs Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025
CANADA
TABLE 43: Canadian Migraine Drugs Market Estimates and Forecasts in US$ Thousand by Treatment: 2018 to 2025
TABLE 44: Canadian Migraine Drugs Historic Market Review by Treatment in US$ Thousand: 2009-2017
TABLE 45: Migraine Drugs Market in Canada: Percentage Share Breakdown of Sales by Treatment for 2009, 2019, and 2025
TABLE 46: Canadian Migraine Drugs Market Estimates and Forecasts in US$ Thousand by Therapeutic Class: 2018 to 2025
TABLE 47: Canadian Migraine Drugs Historic Market Review by Therapeutic Class in US$ Thousand: 2009-2017
TABLE 48: Migraine Drugs Market in Canada: Percentage Share Breakdown of Sales by Therapeutic Class for 2009, 2019, and 2025
TABLE 49: Canadian Migraine Drugs Market Estimates and Forecasts in US$ Thousand by Route of Administration: 2018 to 2025
TABLE 50: Canadian Migraine Drugs Historic Market Review by Route of Administration in US$ Thousand: 2009-2017
TABLE 51: Migraine Drugs Market in Canada: Percentage Share Breakdown of Sales by Route of Administration for 2009, 2019, and 2025
JAPAN
TABLE 52: Japanese Market for Migraine Drugs: Annual Sales Estimates and Projections in US$ Thousand by Treatment for the Period 2018-2025
TABLE 53: Migraine Drugs Market in Japan: Historic Sales Analysis in US$ Thousand by Treatment for the Period 2009-2017
TABLE 54: Japanese Migraine Drugs Market Share Analysis by Treatment: 2009 VS 2019 VS 2025
TABLE 55: Japanese Market for Migraine Drugs: Annual Sales Estimates and Projections in US$ Thousand by Therapeutic Class for the Period 2018-2025
TABLE 56: Migraine Drugs Market in Japan: Historic Sales Analysis in US$ Thousand by Therapeutic Class for the Period 2009-2017
TABLE 57: Japanese Migraine Drugs Market Share Analysis by Therapeutic Class: 2009 VS 2019 VS 2025
TABLE 58: Japanese Market for Migraine Drugs: Annual Sales Estimates and Projections in US$ Thousand by Route of Administration for the Period 2018-2025
TABLE 59: Migraine Drugs Market in Japan: Historic Sales Analysis in US$ Thousand by Route of Administration for the Period 2009-2017
TABLE 60: Japanese Migraine Drugs Market Share Analysis by Route of Administration: 2009 VS 2019 VS 2025
CHINA
TABLE 61: Chinese Migraine Drugs Market Growth Prospects in US$ Thousand by Treatment for the Period 2018-2025
TABLE 62: Migraine Drugs Historic Market Analysis in China in US$ Thousand by Treatment: 2009-2017
TABLE 63: Chinese Migraine Drugs Market by Treatment: Percentage Breakdown of Sales for 2009, 2019, and 2025
TABLE 64: Chinese Migraine Drugs Market Growth Prospects in US$ Thousand by Therapeutic Class for the Period 2018-2025
TABLE 65: Migraine Drugs Historic Market Analysis in China in US$ Thousand by Therapeutic Class: 2009-2017
TABLE 66: Chinese Migraine Drugs Market by Therapeutic Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
TABLE 67: Chinese Migraine Drugs Market Growth Prospects in US$ Thousand by Route of Administration for the Period 2018-2025
TABLE 68: Migraine Drugs Historic Market Analysis in China in US$ Thousand by Route of Administration: 2009-2017
TABLE 69: Chinese Migraine Drugs Market by Route of Administration: Percentage Breakdown of Sales for 2009, 2019, and 2025
EUROPE
Market Facts & Figures
European Migraine Drugs Market: Competitor Market Share Scenario (in %) for 2019 & 2025
TABLE 70: European Migraine Drugs Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025
TABLE 71: Migraine Drugs Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2009-2017
TABLE 72: European Migraine Drugs Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
TABLE 73: European Migraine Drugs Market Estimates and Forecasts in US$ Thousand by Treatment: 2018-2025
TABLE 74: Migraine Drugs Market in Europe in US$ Thousand by Treatment: A Historic Review for the Period 2009-2017
TABLE 75: European Migraine Drugs Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
TABLE 76: European Migraine Drugs Market Estimates and Forecasts in US$ Thousand by Therapeutic Class: 2018-2025
TABLE 77: Migraine Drugs Market in Europe in US$ Thousand by Therapeutic Class: A Historic Review for the Period 2009-2017
TABLE 78: European Migraine Drugs Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
TABLE 79: European Migraine Drugs Market Estimates and Forecasts in US$ Thousand by Route of Administration: 2018-2025
TABLE 80: Migraine Drugs Market in Europe in US$ Thousand by Route of Administration: A Historic Review for the Period 2009-2017
TABLE 81: European Migraine Drugs Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025
FRANCE
TABLE 82: Migraine Drugs Market in France by Treatment: Estimates and Projections in US$ Thousand for the Period 2018-2025
TABLE 83: French Migraine Drugs Historic Market Scenario in US$ Thousand by Treatment: 2009-2017
TABLE 84: French Migraine Drugs Market Share Analysis by Treatment: 2009 VS 2019 VS 2025
TABLE 85: Migraine Drugs Market in France by Therapeutic Class: Estimates and Projections in US$ Thousand for the Period 2018-2025
TABLE 86: French Migraine Drugs Historic Market Scenario in US$ Thousand by Therapeutic Class: 2009-2017
TABLE 87: French Migraine Drugs Market Share Analysis by Therapeutic Class: 2009 VS 2019 VS 2025
TABLE 88: Migraine Drugs Market in France by Route of Administration: Estimates and Projections in US$ Thousand for the Period 2018-2025
TABLE 89: French Migraine Drugs Historic Market Scenario in US$ Thousand by Route of Administration: 2009-2017
TABLE 90: French Migraine Drugs Market Share Analysis by Route of Administration: 2009 VS 2019 VS 2025
GERMANY
TABLE 91: Migraine Drugs Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Treatment for the Period 2018-2025
TABLE 92: German Migraine Drugs Historic Market Analysis in US$ Thousand by Treatment: 2009-2017
TABLE 93: German Migraine Drugs Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
TABLE 94: Migraine Drugs Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Therapeutic Class for the Period 2018-2025
TABLE 95: German Migraine Drugs Historic Market Analysis in US$ Thousand by Therapeutic Class: 2009-2017
TABLE 96: German Migraine Drugs Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
TABLE 97: Migraine Drugs Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Route of Administration for the Period 2018-2025
TABLE 98: German Migraine Drugs Historic Market Analysis in US$ Thousand by Route of Administration: 2009-2017
TABLE 99: German Migraine Drugs Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025
ITALY
TABLE 100: Italian Migraine Drugs Market Growth Prospects in US$ Thousand by Treatment for the Period 2018-2025
TABLE 101: Migraine Drugs Historic Market Analysis in Italy in US$ Thousand by Treatment: 2009-2017
TABLE 102: Italian Migraine Drugs Market by Treatment: Percentage Breakdown of Sales for 2009, 2019, and 2025
TABLE 103: Italian Migraine Drugs Market Growth Prospects in US$ Thousand by Therapeutic Class for the Period 2018-2025
TABLE 104: Migraine Drugs Historic Market Analysis in Italy in US$ Thousand by Therapeutic Class: 2009-2017
TABLE 105: Italian Migraine Drugs Market by Therapeutic Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
TABLE 106: Italian Migraine Drugs Market Growth Prospects in US$ Thousand by Route of Administration for the Period 2018-2025
TABLE 107: Migraine Drugs Historic Market Analysis in Italy in US$ Thousand by Route of Administration: 2009-2017
TABLE 108: Italian Migraine Drugs Market by Route of Administration: Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED KINGDOM
TABLE 109: United Kingdom Market for Migraine Drugs: Annual Sales Estimates and Projections in US$ Thousand by Treatment for the Period 2018-2025
TABLE 110: Migraine Drugs Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Treatment for the Period 2009-2017
TABLE 111: United Kingdom Migraine Drugs Market Share Analysis by Treatment: 2009 VS 2019 VS 2025
TABLE 112: United Kingdom Market for Migraine Drugs: Annual Sales Estimates and Projections in US$ Thousand by Therapeutic Class for the Period 2018-2025
TABLE 113: Migraine Drugs Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Therapeutic Class for the Period 2009-2017
TABLE 114: United Kingdom Migraine Drugs Market Share Analysis by Therapeutic Class: 2009 VS 2019 VS 2025
TABLE 115: United Kingdom Market for Migraine Drugs: Annual Sales Estimates and Projections in US$ Thousand by Route of Administration for the Period 2018-2025
TABLE 116: Migraine Drugs Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Route of Administration for the Period 2009-2017
TABLE 117: United Kingdom Migraine Drugs Market Share Analysis by Route of Administration: 2009 VS 2019 VS 2025
SPAIN
TABLE 118: Spanish Migraine Drugs Market Estimates and Forecasts in US$ Thousand by Treatment: 2018 to 2025
TABLE 119: Spanish Migraine Drugs Historic Market Review by Treatment in US$ Thousand: 2009-2017
TABLE 120: Migraine Drugs Market in Spain: Percentage Share Breakdown of Sales by Treatment for 2009, 2019, and 2025
TABLE 121: Spanish Migraine Drugs Market Estimates and Forecasts in US$ Thousand by Therapeutic Class: 2018 to 2025
TABLE 122: Spanish Migraine Drugs Historic Market Review by Therapeutic Class in US$ Thousand: 2009-2017
TABLE 123: Migraine Drugs Market in Spain: Percentage Share Breakdown of Sales by Therapeutic Class for 2009, 2019, and 2025
TABLE 124: Spanish Migraine Drugs Market Estimates and Forecasts in US$ Thousand by Route of Administration: 2018 to 2025
TABLE 125: Spanish Migraine Drugs Historic Market Review by Route of Administration in US$ Thousand: 2009-2017
TABLE 126: Migraine Drugs Market in Spain: Percentage Share Breakdown of Sales by Route of Administration for 2009, 2019, and 2025
RUSSIA
TABLE 127: Russian Migraine Drugs Market Estimates and Projections in US$ Thousand by Treatment: 2018 to 2025
TABLE 128: Migraine Drugs Market in Russia by Treatment: A Historic Review in US$ Thousand for 2009-2017
TABLE 129: Russian Migraine Drugs Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
TABLE 130: Russian Migraine Drugs Market Estimates and Projections in US$ Thousand by Therapeutic Class: 2018 to 2025
TABLE 131: Migraine Drugs Market in Russia by Therapeutic Class: A Historic Review in US$ Thousand for 2009-2017
TABLE 132: Russian Migraine Drugs Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
TABLE 133: Russian Migraine Drugs Market Estimates and Projections in US$ Thousand by Route of Administration: 2018 to 2025
TABLE 134: Migraine Drugs Market in Russia by Route of Administration: A Historic Review in US$ Thousand for 2009-2017
TABLE 135: Russian Migraine Drugs Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025
REST OF EUROPE
TABLE 136: Rest of Europe Migraine Drugs Market Estimates and Forecasts in US$ Thousand by Treatment: 2018-2025
TABLE 137: Migraine Drugs Market in Rest of Europe in US$ Thousand by Treatment: A Historic Review for the Period 2009-2017
TABLE 138: Rest of Europe Migraine Drugs Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
TABLE 139: Rest of Europe Migraine Drugs Market Estimates and Forecasts in US$ Thousand by Therapeutic Class: 2018-2025
TABLE 140: Migraine Drugs Market in Rest of Europe in US$ Thousand by Therapeutic Class: A Historic Review for the Period 2009-2017
TABLE 141: Rest of Europe Migraine Drugs Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
TABLE 142: Rest of Europe Migraine Drugs Market Estimates and Forecasts in US$ Thousand by Route of Administration: 2018-2025
TABLE 143: Migraine Drugs Market in Rest of Europe in US$ Thousand by Route of Administration: A Historic Review for the Period 2009-2017
TABLE 144: Rest of Europe Migraine Drugs Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025
ASIA-PACIFIC
TABLE 145: Asia-Pacific Migraine Drugs Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025
TABLE 146: Migraine Drugs Market in Asia-Pacific: Historic Market Analysis in US$ Thousand by Region/Country for the Period 2009-2017
TABLE 147: Asia-Pacific Migraine Drugs Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
TABLE 148: Migraine Drugs Market in Asia-Pacific by Treatment: Estimates and Projections in US$ Thousand for the Period 2018-2025
TABLE 149: Asia-Pacific Migraine Drugs Historic Market Scenario in US$ Thousand by Treatment: 2009-2017
TABLE 150: Asia-Pacific Migraine Drugs Market Share Analysis by Treatment: 2009 VS 2019 VS 2025
TABLE 151: Migraine Drugs Market in Asia-Pacific by Therapeutic Class: Estimates and Projections in US$ Thousand for the Period 2018-2025
TABLE 152: Asia-Pacific Migraine Drugs Historic Market Scenario in US$ Thousand by Therapeutic Class: 2009-2017
TABLE 153: Asia-Pacific Migraine Drugs Market Share Analysis by Therapeutic Class: 2009 VS 2019 VS 2025
TABLE 154: Migraine Drugs Market in Asia-Pacific by Route of Administration: Estimates and Projections in US$ Thousand for the Period 2018-2025
TABLE 155: Asia-Pacific Migraine Drugs Historic Market Scenario in US$ Thousand by Route of Administration: 2009-2017
TABLE 156: Asia-Pacific Migraine Drugs Market Share Analysis by Route of Administration: 2009 VS 2019 VS 2025
AUSTRALIA
TABLE 157: Migraine Drugs Market in Australia: Recent Past, Current and Future Analysis in US$ Thousand by Treatment for the Period 2018-2025
TABLE 158: Australian Migraine Drugs Historic Market Analysis in US$ Thousand by Treatment: 2009-2017
TABLE 159: Australian Migraine Drugs Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
TABLE 160: Migraine Drugs Market in Australia: Recent Past, Current and Future Analysis in US$ Thousand by Therapeutic Class for the Period 2018-2025
TABLE 161: Australian Migraine Drugs Historic Market Analysis in US$ Thousand by Therapeutic Class: 2009-2017
TABLE 162: Australian Migraine Drugs Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
TABLE 163: Migraine Drugs Market in Australia: Recent Past, Current and Future Analysis in US$ Thousand by Route of Administration for the Period 2018-2025
TABLE 164: Australian Migraine Drugs Historic Market Analysis in US$ Thousand by Route of Administration: 2009-2017
TABLE 165: Australian Migraine Drugs Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025
INDIA
TABLE 166: Indian Migraine Drugs Market Estimates and Forecasts in US$ Thousand by Treatment: 2018 to 2025
TABLE 167: Indian Migraine Drugs Historic Market Review by Treatment in US$ Thousand: 2009-2017
TABLE 168: Migraine Drugs Market in India: Percentage Share Breakdown of Sales by Treatment for 2009, 2019, and 2025
TABLE 169: Indian Migraine Drugs Market Estimates and Forecasts in US$ Thousand by Therapeutic Class: 2018 to 2025
TABLE 170: Indian Migraine Drugs Historic Market Review by Therapeutic Class in US$ Thousand: 2009-2017
TABLE 171: Migraine Drugs Market in India: Percentage Share Breakdown of Sales by Therapeutic Class for 2009, 2019, and 2025
TABLE 172: Indian Migraine Drugs Market Estimates and Forecasts in US$ Thousand by Route of Administration: 2018 to 2025
TABLE 173: Indian Migraine Drugs Historic Market Review by Route of Administration in US$ Thousand: 2009-2017
TABLE 174: Migraine Drugs Market in India: Percentage Share Breakdown of Sales by Route of Administration for 2009, 2019, and 2025
SOUTH KOREA
TABLE 175: Migraine Drugs Market in South Korea: Recent Past, Current and Future Analysis in US$ Thousand by Treatment for the Period 2018-2025
TABLE 176: South Korean Migraine Drugs Historic Market Analysis in US$ Thousand by Treatment: 2009-2017
TABLE 177: Migraine Drugs Market Share Distribution in South Korea by Treatment: 2009 VS 2019 VS 2025
TABLE 178: Migraine Drugs Market in South Korea: Recent Past, Current and Future Analysis in US$ Thousand by Therapeutic Class for the Period 2018-2025
TABLE 179: South Korean Migraine Drugs Historic Market Analysis in US$ Thousand by Therapeutic Class: 2009-2017
TABLE 180: Migraine Drugs Market Share Distribution in South Korea by Therapeutic Class: 2009 VS 2019 VS 2025
TABLE 181: Migraine Drugs Market in South Korea: Recent Past, Current and Future Analysis in US$ Thousand by Route of Administration for the Period 2018-2025
TABLE 182: South Korean Migraine Drugs Historic Market Analysis in US$ Thousand by Route of Administration: 2009-2017
TABLE 183: Migraine Drugs Market Share Distribution in South Korea by Route of Administration: 2009 VS 2019 VS 2025
REST OF ASIA-PACIFIC
TABLE 184: Rest of Asia-Pacific Market for Migraine Drugs: Annual Sales Estimates and Projections in US$ Thousand by Treatment for the Period 2018-2025
TABLE 185: Migraine Drugs Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Thousand by Treatment for the Period 2009-2017
TABLE 186: Rest of Asia-Pacific Migraine Drugs Market Share Analysis by Treatment: 2009 VS 2019 VS 2025
TABLE 187: Rest of Asia-Pacific Market for Migraine Drugs: Annual Sales Estimates and Projections in US$ Thousand by Therapeutic Class for the Period 2018-2025
TABLE 188: Migraine Drugs Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Thousand by Therapeutic Class for the Period 2009-2017
TABLE 189: Rest of Asia-Pacific Migraine Drugs Market Share Analysis by Therapeutic Class: 2009 VS 2019 VS 2025
TABLE 190: Rest of Asia-Pacific Market for Migraine Drugs: Annual Sales Estimates and Projections in US$ Thousand by Route of Administration for the Period 2018-2025
TABLE 191: Migraine Drugs Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Thousand by Route of Administration for the Period 2009-2017
TABLE 192: Rest of Asia-Pacific Migraine Drugs Market Share Analysis by Route of Administration: 2009 VS 2019 VS 2025
LATIN AMERICA
TABLE 193: Latin American Migraine Drugs Market Trends by Region/Country in US$ Thousand: 2018-2025
T¬¬ABLE 194: Migraine Drugs Market in Latin America in US$ Thousand by Region/Country: A Historic Perspective for the Period 2009-2017
TABLE 195: Latin American Migraine Drugs Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025
TABLE 196: Latin American Migraine Drugs Market Growth Prospects in US$ Thousand by Treatment for the Period 2018-2025
TABLE 197: Migraine Drugs Historic Market Analysis in Latin America in US$ Thousand by Treatment: 2009-2017
TABLE 198: Latin American Migraine Drugs Market by Treatment: Percentage Breakdown of Sales for 2009, 2019, and 2025
TABLE 199: Latin American Migraine Drugs Market Growth Prospects in US$ Thousand by Therapeutic Class for the Period 2018-2025
TABLE 200: Migraine Drugs Historic Market Analysis in Latin America in US$ Thousand by Therapeutic Class: 2009-2017
TABLE 201: Latin American Migraine Drugs Market by Therapeutic Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
TABLE 202: Latin American Migraine Drugs Market Growth Prospects in US$ Thousand by Route of Administration for the Period 2018-2025
TABLE 203: Migraine Drugs Historic Market Analysis in Latin America in US$ Thousand by Route of Administration: 2009-2017
TABLE 204: Latin American Migraine Drugs Market by Route of Administration: Percentage Breakdown of Sales for 2009, 2019, and 2025
ARGENTINA
TABLE 205: Argentinean Migraine Drugs Market Estimates and Forecasts in US$ Thousand by Treatment: 2018-2025
TABLE 206: Migraine Drugs Market in Argentina in US$ Thousand by Treatment: A Historic Review for the Period 2009-2017
TABLE 207: Argentinean Migraine Drugs Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
TABLE 208: Argentinean Migraine Drugs Market Estimates and Forecasts in US$ Thousand by Therapeutic Class: 2018-2025
TABLE 209: Migraine Drugs Market in Argentina in US$ Thousand by Therapeutic Class: A Historic Review for the Period 2009-2017
TABLE 210: Argentinean Migraine Drugs Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
TABLE 211: Argentinean Migraine Drugs Market Estimates and Forecasts in US$ Thousand by Route of Administration: 2018-2025
TABLE 212: Migraine Drugs Market in Argentina in US$ Thousand by Route of Administration: A Historic Review for the Period 2009-2017
TABLE 213: Argentinean Migraine Drugs Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025
BRAZIL
TABLE 214: Migraine Drugs Market in Brazil by Treatment: Estimates and Projections in US$ Thousand for the Period 2018-2025
TABLE 215: Brazilian Migraine Drugs Historic Market Scenario in US$ Thousand by Treatment: 2009-2017
TABLE 216: Brazilian Migraine Drugs Market Share Analysis by Treatment: 2009 VS 2019 VS 2025
TABLE 217: Migraine Drugs Market in Brazil by Therapeutic Class: Estimates and Projections in US$ Thousand for the Period 2018-2025
TABLE 218: Brazilian Migraine Drugs Historic Market Scenario in US$ Thousand by Therapeutic Class: 2009-2017
TABLE 219: Brazilian Migraine Drugs Market Share Analysis by Therapeutic Class: 2009 VS 2019 VS 2025
TABLE 220: Migraine Drugs Market in Brazil by Route of Administration: Estimates and Projections in US$ Thousand for the Period 2018-2025
TABLE 221: Brazilian Migraine Drugs Historic Market Scenario in US$ Thousand by Route of Administration: 2009-2017
TABLE 222: Brazilian Migraine Drugs Market Share Analysis by Route of Administration: 2009 VS 2019 VS 2025
MEXICO
TABLE 223: Migraine Drugs Market in Mexico: Recent Past, Current and Future Analysis in US$ Thousand by Treatment for the Period 2018-2025
TABLE 224: Mexican Migraine Drugs Historic Market Analysis in US$ Thousand by Treatment: 2009-2017
TABLE 225: Mexican Migraine Drugs Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
TABLE 226: Migraine Drugs Market in Mexico: Recent Past, Current and Future Analysis in US$ Thousand by Therapeutic Class for the Period 2018-2025
TABLE 227: Mexican Migraine Drugs Historic Market Analysis in US$ Thousand by Therapeutic Class: 2009-2017
TABLE 228: Mexican Migraine Drugs Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
TABLE 229: Migraine Drugs Market in Mexico: Recent Past, Current and Future Analysis in US$ Thousand by Route of Administration for the Period 2018-2025
TABLE 230: Mexican Migraine Drugs Historic Market Analysis in US$ Thousand by Route of Administration: 2009-2017
TABLE 231: Mexican Migraine Drugs Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025
REST OF LATIN AMERICA
TABLE 232: Rest of Latin America Migraine Drugs Market Estimates and Projections in US$ Thousand by Treatment: 2018 to 2025
TABLE 233: Migraine Drugs Market in Rest of Latin America by Treatment: A Historic Review in US$ Thousand for 2009-2017
TABLE 234: Rest of Latin America Migraine Drugs Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
TABLE 235: Rest of Latin America Migraine Drugs Market Estimates and Projections in US$ Thousand by Therapeutic Class: 2018 to 2025
TABLE 236: Migraine Drugs Market in Rest of Latin America by Therapeutic Class: A Historic Review in US$ Thousand for 2009-2017
TABLE 237: Rest of Latin America Migraine Drugs Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
TABLE 238: Rest of Latin America Migraine Drugs Market Estimates and Projections in US$ Thousand by Route of Administration: 2018 to 2025
TABLE 239: Migraine Drugs Market in Rest of Latin America by Route of Administration: A Historic Review in US$ Thousand for 2009-2017
TABLE 240: Rest of Latin America Migraine Drugs Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025
MIDDLE EAST
TABLE 241: The Middle East Migraine Drugs Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025
TABLE 242: Migraine Drugs Market in the Middle East by Region/Country in US$ Thousand: 2009-2017
TABLE 243: The Middle East Migraine Drugs Market Share Breakdown by Region/Country: 2009, 2019, and 2025
TABLE 244: The Middle East Migraine Drugs Market Estimates and Forecasts in US$ Thousand by Treatment: 2018 to 2025
TABLE 245: The Middle East Migraine Drugs Historic Market by Treatment in US$ Thousand: 2009-2017
TABLE 246: Migraine Drugs Market in the Middle East: Percentage Share Breakdown of Sales by Treatment for 2009, 2019, and 2025
TABLE 247: The Middle East Migraine Drugs Market Estimates and Forecasts in US$ Thousand by Therapeutic Class: 2018 to 2025
TABLE 248: The Middle East Migraine Drugs Historic Market by Therapeutic Class in US$ Thousand: 2009-2017
TABLE 249: Migraine Drugs Market in the Middle East: Percentage Share Breakdown of Sales by Therapeutic Class for 2009, 2019, and 2025
TABLE 250: The Middle East Migraine Drugs Market Estimates and Forecasts in US$ Thousand by Route of Administration: 2018 to 2025
TABLE 251: The Middle East Migraine Drugs Historic Market by Route of Administration in US$ Thousand: 2009-2017
TABLE 252: Migraine Drugs Market in the Middle East: Percentage Share Breakdown of Sales by Route of Administration for 2009, 2019, and 2025
IRAN
TABLE 253: Iranian Market for Migraine Drugs: Annual Sales Estimates and Projections in US$ Thousand by Treatment for the Period 2018-2025
TABLE 254: Migraine Drugs Market in Iran: Historic Sales Analysis in US$ Thousand by Treatment for the Period 2009-2017
TABLE 255: Iranian Migraine Drugs Market Share Analysis by Treatment: 2009 VS 2019 VS 2025
TABLE 256: Iranian Market for Migraine Drugs: Annual Sales Estimates and Projections in US$ Thousand by Therapeutic Class for the Period 2018-2025
TABLE 257: Migraine Drugs Market in Iran: Historic Sales Analysis in US$ Thousand by Therapeutic Class for the Period 2009-2017
TABLE 258: Iranian Migraine Drugs Market Share Analysis by Therapeutic Class: 2009 VS 2019 VS 2025
TABLE 259: Iranian Market for Migraine Drugs: Annual Sales Estimates and Projections in US$ Thousand by Route of Administration for the Period 2018-2025
TABLE 260: Migraine Drugs Market in Iran: Historic Sales Analysis in US$ Thousand by Route of Administration for the Period 2009-2017
TABLE 261: Iranian Migraine Drugs Market Share Analysis by Route of Administration: 2009 VS 2019 VS 2025
ISRAEL
TABLE 262: Israeli Migraine Drugs Market Estimates and Forecasts in US$ Thousand by Treatment: 2018-2025
TABLE 263: Migraine Drugs Market in Israel in US$ Thousand by Treatment: A Historic Review for the Period 2009-2017
TABLE 264: Israeli Migraine Drugs Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
TABLE 265: Israeli Migraine Drugs Market Estimates and Forecasts in US$ Thousand by Therapeutic Class: 2018-2025
TABLE 266: Migraine Drugs Market in Israel in US$ Thousand by Therapeutic Class: A Historic Review for the Period 2009-2017
TABLE 267: Israeli Migraine Drugs Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
TABLE 268: Israeli Migraine Drugs Market Estimates and Forecasts in US$ Thousand by Route of Administration: 2018-2025
TABLE 269: Migraine Drugs Market in Israel in US$ Thousand by Route of Administration: A Historic Review for the Period 2009-2017
TABLE 270: Israeli Migraine Drugs Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025
SAUDI ARABIA
TABLE 271: Saudi Arabian Migraine Drugs Market Growth Prospects in US$ Thousand by Treatment for the Period 2018-2025
TABLE 272: Migraine Drugs Historic Market Analysis in Saudi Arabia in US$ Thousand by Treatment: 2009-2017
TABLE 273: Saudi Arabian Migraine Drugs Market by Treatment: Percentage Breakdown of Sales for 2009, 2019, and 2025
TABLE 274: Saudi Arabian Migraine Drugs Market Growth Prospects in US$ Thousand by Therapeutic Class for the Period 2018-2025
TABLE 275: Migraine Drugs Historic Market Analysis in Saudi Arabia in US$ Thousand by Therapeutic Class: 2009-2017
TABLE 276: Saudi Arabian Migraine Drugs Market by Therapeutic Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
TABLE 277: Saudi Arabian Migraine Drugs Market Growth Prospects in US$ Thousand by Route of Administration for the Period 2018-2025
TABLE 278: Migraine Drugs Historic Market Analysis in Saudi Arabia in US$ Thousand by Route of Administration: 2009-2017
TABLE 279: Saudi Arabian Migraine Drugs Market by Route of Administration: Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED ARAB EMIRATES
TABLE 280: Migraine Drugs Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Thousand by Treatment for the Period 2018-2025
TABLE 281: United Arab Emirates Migraine Drugs Historic Market Analysis in US$ Thousand by Treatment: 2009-2017
TABLE 282: Migraine Drugs Market Share Distribution in United Arab Emirates by Treatment: 2009 VS 2019 VS 2025
TABLE 283: Migraine Drugs Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Thousand by Therapeutic Class for the Period 2018-2025
TABLE 284: United Arab Emirates Migraine Drugs Historic Market Analysis in US$ Thousand by Therapeutic Class: 2009-2017
TABLE 285: Migraine Drugs Market Share Distribution in United Arab Emirates by Therapeutic Class: 2009 VS 2019 VS 2025
TABLE 286: Migraine Drugs Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Thousand by Route of Administration for the Period 2018-2025
TABLE 287: United Arab Emirates Migraine Drugs Historic Market Analysis in US$ Thousand by Route of Administration: 2009-2017
TABLE 288: Migraine Drugs Market Share Distribution in United Arab Emirates by Route of Administration: 2009 VS 2019 VS 2025
REST OF MIDDLE EAST
TABLE 289: Migraine Drugs Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Thousand by Treatment for the Period 2018-2025
TABLE 290: Rest of Middle East Migraine Drugs Historic Market Analysis in US$ Thousand by Treatment: 2009-2017
TABLE 291: Rest of Middle East Migraine Drugs Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
TABLE 292: Migraine Drugs Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Thousand by Therapeutic Class for the Period 2018-2025
TABLE 293: Rest of Middle East Migraine Drugs Historic Market Analysis in US$ Thousand by Therapeutic Class: 2009-2017
TABLE 294: Rest of Middle East Migraine Drugs Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
TABLE 295: Migraine Drugs Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Thousand by Route of Administration for the Period 2018-2025
TABLE 296: Rest of Middle East Migraine Drugs Historic Market Analysis in US$ Thousand by Route of Administration: 2009-2017
TABLE 297: Rest of Middle East Migraine Drugs Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025
AFRICA
TABLE 298: African Migraine Drugs Market Estimates and Projections in US$ Thousand by Treatment: 2018 to 2025
TABLE 299: Migraine Drugs Market in Africa by Treatment: A Historic Review in US$ Thousand for 2009-2017
TABLE 300: African Migraine Drugs Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
TABLE 301: African Migraine Drugs Market Estimates and Projections in US$ Thousand by Therapeutic Class: 2018 to 2025
TABLE 302: Migraine Drugs Market in Africa by Therapeutic Class: A Historic Review in US$ Thousand for 2009-2017
TABLE 303: African Migraine Drugs Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
TABLE 304: African Migraine Drugs Market Estimates and Projections in US$ Thousand by Route of Administration: 2018 to 2025
TABLE 305: Migraine Drugs Market in Africa by Route of Administration: A Historic Review in US$ Thousand for 2009-2017
TABLE 306: African Migraine Drugs Market Share Breakdown by Route of Administration: 2009 VS 2019 VS 2025
IV. COMPETITION
ALLERGAN PLC
AMGEN
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
ELI LILLY AND COMPANY
GLAXOSMITHKLINE PLC
JOHNSON & JOHNSON
PFIZER
TEVA PHARMACEUTICAL INDUSTRIES
V. CURATED RESEARCH

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook